Regulatory effects of interleukin- 1β and prostaglandin E2 on expression of receptor activator of nuclear factor-κB ligand in human periodontal ligament cells

Journal of Periodontology

Volumn 75, Issue 2, 2004, Pages 249-259

  Nukaga, Jun ^a   Kobayashi, Makoto ^a   Shinki, Toshimasa ^a   Song, Hong ^b   Takada, Takatora ^a   Takiguchi, Takashi ^a   Kamijo, Ryutarou ^a   Hasegawa, Kohji ^a  

^a SHOWA UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bone resorption; Interleukin 1; NF kappa; Osteoclasts; Periodontal ligament anatomy and histology; Periodontitis pathogenesis; Prostaglandin E2; Receptors, cell surface; Upregulation

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; BUCLADESINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; FORSKOLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; INTERLEUKIN 1; ISOBUTYLMETHYLXANTHINE; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; OSTEOCLAST DIFFERENTIATION FACTOR; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROTEIN KINASE C INHIBITOR;

ARTICLE; CELL CULTURE; CELL POPULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; OSTEOBLAST; PERIODONTAL LIGAMENT; PERIODONTITIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

1-METHYL-3-ISOBUTYLXANTHINE; ADOLESCENT; ADULT; BUCLADESINE; CARRIER PROTEINS; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; FEMALE; FORSKOLIN; HUMANS; INTERLEUKIN-1; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; OSTEOCLASTS; PERIODONTAL LIGAMENT; PHOSPHODIESTERASE INHIBITORS; PROTEIN KINASE C; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, PROSTAGLANDIN E; RNA, MESSENGER;

EID: 1642313645     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.2.249     Document Type: Article

References (59)

1. Charon JA, Luger TA, Mergenhagen SE, Oppenheim JJ. Increased thymocyte-activating factor in human gingival fluid during gingival inflammation. Infect Immun 1982;38:1190-1195.
2. Masada MP, Persson R, Kenney JS, Lee SW, Page RC, Allison AC. Measurement of interleukin-1 alpha and -1 beta in gingival crevicular fluid: Implications for the pathogenesis of periodontal disease. J Periodont Res 1990;25:156-163.
3. Jandinski JJ, Stashenko P, Feder LS, et al. Localization of interleukin-1 beta in human periodontal tissue. J Periodontol 1991;62:36-43.
4. Stashenko P, Fujiyoshi P, Obernesser MS, Prostak L, Haffajee AD, Socransky SS. Levels of interleukin 1 beta in tissue from sites of active periodontal disease. J Clin Periodontol 1991;18:548-554.
5. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-444.
6. Loning T, Albers HK, Lisboa BP, Burkhardt A, Caselitz J. Prostaglandin E and the local immune response in chronic periodontal disease. Immunohistochemical and radioimmunological observations. J Periodontal Res 1980;15:525-535.
7. Offenbacher S, Farr DH, Goodson JM. Measurement of prostaglandin E in crevicular fluid. J Clin Periodontol 1981;8:359-367.
8. Boyce BF, Aufdemorte TB, Garrett IR, Yates AJ, Mundy GR. Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 1989;125:1142-1150.
9. Gowen M, Wood DD, Ihrie EJ, McGuire MK, Russell RG. An interleukin 1-like factor stimulates bone resorption in vitro. Nature 1983;306:378-380.
10. Lorenzo JA, Sousa SL, Alander C, Raisz LG, Dinarello CA. Comparison of the bone-resorbing activity in the supernatants from phytohemagglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin 1. Endocrinology 1987;121:1164-1170.
11. Jimi E, Akiyama S, Tsurukai T, et al. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol 1999;163:434-442.
12. Jimi E, Nakamura I, Duong LT, et al. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res 1999;247:84-93.
13. Dinarello CA. The interleukin-1 family: 10 years of discovery. FASEB J 1994;8:1314-1325.
14. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999;20: 345-357.
15. Raisz LG, Vanderhoek JY, Simmons HA, Kream BE, Nicolaou KC. Prostaglandin synthesis by fetal rat bone in vitro: Evidence for a role of prostacyclin. Prostaglandins 1979;17:905-914.
16. 2 and bone resorption by recombinant human interleukin 1 alpha in fetal mouse bones. Biochem Biophys Res Commun 1986;138: 618-624.
17. Akatsu T, Takahashi N, Udagawa N, et al. Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J Bone Miner Res 1991;6:183-189.
18. 2 stimulates osteoclast formation via endogenous IL-1 beta expressed through protein kinase A. J Immunol 1996;156: 1931-1936.
19. Anderson DM, Maraskovsky E, Billingsley WL, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997; 390:175-179.
20. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci (USA) 1998;95:3597-3602.
21. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-176.
22. Wong BR, Rho J, Arron J, et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 1997;272:25190-25194.
23. Takahashi N, Udagawa N, Suda T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun 1999;256: 449-455.
24. Fuller K, Wong B, Fox S, Choi Y, Chambers TJ. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 1998; 188:997-1001.
25. 2, or parathyroid hormone in the microenvironment of bone. Biochem Biophys Res Commun 1998;246:337-341.
26. Somerman MJ, Archer SY, Imm GR, Foster RA. A comparative study of human periodontal ligament cells and gingival fibroblasts in vitro. J Dent Res 1988; 67:66-70.
27. Arceo N, Sauk JJ, Moehring J, Foster RA, Somerman MJ. Human periodontal cells initiate mineral-like nodules in vitro. J Periodontol 1991;62:499-503.
28. Kobayashi M, Takiguchi T, Suzuki R, et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic differentiation in cells isolated from human periodontal ligament. J Dent Res 1999;78:1624-1633.
29. Okada N, Kobayashi M, Mugikura K, et al. Interleukin-6 production in human fibroblasts derived from periodontal tissues is differentially regulated by cytokines and a glucocorticoid. J Periodont Res 1997;32:559-569.
30. Shimizu N, Ogura N, Yamaguchi MT, et al. Stimulation by interleukin-1 of interleukin-6 production by human periodontal ligament cells. Arch Oral Biol 1992;37: 743-748.
31. Hayashi Y, Kobayashi M, Kuwata H, et al. Interferon-gamma and interleukin 4 inhibit interleukin 1beta-induced delayed prostaglandin E(2) generation through suppression of cyclooxygenase-2 expression in human fibroblasts. Cytokine 2000;12:603-612.
32. Kanzaki H, Chiba M, Shimizu Y, Mitani H. Dual regulation of osteoclast differentiation by periodontal ligament cells through RANKL stimulation and OPG inhibitation. J Dent Res 2001;80:887-891.
33. Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. Interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 1999;25:255-259.
34. Li X, Okada Y, Pilbeam CC, et al. Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro. Endocrinology 2000;141:2054-2061.
35. Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994;46:205-229.
36. Tai H, Miyaura C, Pilbeam CC, et al. Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation. Endocrinology 1997;138:2372-2379.
37. 2 synthesis in mouse osteoblasts cultured with interleukin-1. J Biol Chem 1997;272:5952-5958.
38. Watabe A, Sugimoto Y, Honda A, et al. Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. J Biol Chem 1993;268:20175-20178.
39. Katsuyama M, Nishigaki N, Sugimoto Y, et al. The mouse prostaglandin E receptor EP2 subtype: Cloning, expression, and Northern blot analysis. FEBS Lett 1995;372: 151-156.
40. Segi E, Sugimoto Y, Yamasaki A, et al. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem Biophys Res Commun 1998;246:7-12.
41. Woodiel FN, Fall PM, Raisz LG. Anabolic effects of prostaglandins in cultured fetal rat calvariae: Structure-activity relations and signal transduction pathway. J Bone Miner Res 1996;11:1249-1255.
42. Suzawa T, Miyaura C, Inada M, et al. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: An analysis using specific agonists for the respective EPs. Endocrinology 2000;141: 1554-1559.
43. 2 in prostaglandin E receptor EP4-knockout mice. J Biol Chem 2000;275:19819-19823.
44. Tomita M, Li X, Okada Y, et al. Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro. Bone 2002;30:159-163.
45. 2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. Bone 2002;30:567-573.
46. Matsuzaki K, Katayama K, Takahashi Y, et al. Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a co-culture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene. Endocrinology 1999;140:925-932.
47. 2 synthesis. J Bone Miner Res 2002;17:210-220.
48. Bamba H, Ota S, Kato A, Kawamoto C, Fujiwara K. Prostaglandins upregulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells. Biochem Biophys Res Commun 2000; 273:485-491.
49. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997;89:309-319.
50. Tsuda E, Goto M, Mochizuki S, et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 1997;234:137-142.
51. Yasuda H, Shima N, Nakagawa N, et al. Identity of osteoclastogenesis inhibitory factor(OCIF) and osteoprotegerin(OPG): A mechanism by which OPG/OCIF inhibits osteoclasteogenesis in vitro. Endocrinology 1998;139: 1329-1337.
52. Sakata M, Shiba H, Komatsuzawa H, et al. Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells. J Bone Miner Res 1999;14:1486-1492.
53. Vidal ON, Sjogren K, Eriksson BI, Ljunggren O, Ohlsson C. Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells. Biochem Biophys Res Commun 1998;248:696-700.
54. Horwood NJ, Elliott J, Martin TJ, Gillespie MT. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 1998;139:4743-4746.
55. Sakata M, Shiba H, Komatsuzawa H, et al. Osteoprotegerin levels increased by interleukin-1beta in human periodontal ligament cells are suppressed through prostaglandin E(2) synthesized de novo. Cytokine 2002; 18:133-139.
56. 2 in human bone marrow stroma cells. Biochem Biophys Res Commun 1998; 247:338-341.
57. Takami M, Takahashi N, Udagawa N, et al. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts. Endocrinology 2000;141: 4711-4719.
58. Lee SK, Lorenzo JA. Regulation of receptor activation of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by the protein kinase a pathway in murine bone marrow cultures. Bone 2002;31:252-259.
59. 2-induced interleukin-6 release in astrocytes: Possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C. J Neurochem 2001;79:950-958.